Literature DB >> 9088403

Quantitative determination of aqueous flare and cells in healthy eyes.

O M Guillén-Monterrubío1, J Hartikainen, K Taskinen, K M Saari.   

Abstract

We studied 263 eyes of 141 normal subjects, 33 men and 108 women, including 129 Finns and 12 Ibero-Americans, with the age ranging between 12 and 89 (mean 43.0 +/- 20.4) years using the Kowa FC-1000 laser flare cell meter. The mean photon count/ms was 4.5, it was 3.1 in the age groups of 10-19 years and 11.5 in the age group of 80 years or over; the increase with age was statistically significant (p = 0.0001). There were no significant differences in the photon count/ms between right and left eyes (p = 0.75), between sexes (p = 0.61), or between Ibero-Americans and age-matched Finns (p = 0.62). The mean cell count was 1.1 and there were no significant changes between the right and left eyes (p = 0.56) or between different age (p = 0.38), sex (p = 0.32) and race (p = 0.64) groups. There were no significant differences in the mean photon count/ms (p = 0.97) and cell counts (p = 0.35) between the first and second measurements 5 min later. There was no subject-within variability after 24 h and 7 days in the flare (p = 0.95) and cell counts (p = 0.89).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088403     DOI: 10.1111/j.1600-0420.1997.tb00251.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  12 in total

1.  The effect of a preoperative subconjunctival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery.

Authors:  Young-Hoon Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-15       Impact factor: 3.117

Review 2.  Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-05-09       Impact factor: 2.031

3.  Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.

Authors:  Masahide Kawamura; Masahiro Zako
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

4.  Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis.

Authors:  Ilknur Tugal-Tutkun; Kürsat Cingü; Nur Kir; Baris Yeniad; Meri Urgancioglu; Ahmet Gül
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-27       Impact factor: 3.117

5.  Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease.

Authors:  F D Verbraak; M C Schreinemachers; A Tiller; S J van Deventer; M D de Smet
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

6.  Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.

Authors:  Ph A Kestelyn; Ph G Kestelyn; D De Bacquer; A M Stevens
Journal:  Int Ophthalmol       Date:  2017-12-22       Impact factor: 2.031

7.  Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.

Authors:  K Matti Saari; Laura Nelimarkka; Virpi Ahola; Thorsteinn Loftsson; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-11       Impact factor: 3.117

8.  Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.

Authors:  A Kłysik; M Kozakiewicz
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

9.  Changes in intraocular pressure after pharmacologic pupil dilation.

Authors:  Joon Mo Kim; Ki Ho Park; So Young Han; Kwan Soo Kim; Dong Myung Kim; Tae Woo Kim; Joseph Caprioli
Journal:  BMC Ophthalmol       Date:  2012-09-27       Impact factor: 2.209

10.  Damage to the blood-aqueous barrier in eyes with primary angle closure glaucoma.

Authors:  Xiangyun Kong; Xing Liu; Xiangkun Huang; Zhen Mao; Yimin Zhong; Wei Chi
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.